College of Medicine

Elliott Lab (Nanoparticle Immunotherapy)

Led by Leighton A Elliott · Medicine (Hematology and Oncology)

Auto-generated from UF undergraduate research symposium abstracts

What we study

The lab develops cancer treatments that use tiny lipid and RNA nanoparticles to train the immune system to attack tumors. The goal is to pair these vaccines with immunotherapy so advanced cancers can be treated with less surgery and fewer side effects. Current work focuses on sarcoma and melanoma.

Cancer ResearchBiomedical Engineering

What working here is like

  • Wet lab
  • Clinical
  • Cells in a dish
  • No coding
Projects
2

Current projects

RNA-nanoparticle vaccine for ARMS

An RNA-nanoparticle vaccine for alveolar rhabdomyosarcoma.

RNA-nanoparticle vaccine for melanoma recurrence

A vaccine for early melanoma recurrence after adjuvant anti-PD-1 therapy.

Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.

How to reach out

Leighton A Elliott hasn't set up this page yet. You can also look them up in the UF directory (search “Leighton A Elliott”).

Log in to save this lab, see how to contact the PI, and write your outreach email.

Are you in this lab?Claim this lab

Open positions

No positions posted right now. Many labs still take undergrads who reach out to them, so see how to get in touch.
Elliott Lab (Nanoparticle Immunotherapy) · Leighton A Elliott | JoinLattice